文献速递神经核医学肿瘤 PET/CT

在记忆门诊通过影像生物标志物应用A/T/N模型

The A/T/N model applied through imaging biomarkers in a memory clinic.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2019-12-02

该研究在81例主观或客观认知障碍的记忆门诊患者中,通过淀粉样蛋白PET和结构MRI判定A和N状态,并用18F-flortaucipir PET评估T分布,发现A+N+和A+N-亚组tau负荷高于A-N-组,A/T/N分类中58%属于阿尔茨海默病连续谱。

要点

  • A+N+和A+N-亚组tau负荷高于A-N-组,A+N-的显著沉积限于内侧和外侧颞叶。
  • A/T/N分类中23%生物标志物全阴性,58%属阿尔茨海默病连续谱,19%为非AD病理改变。
  • 作者认为结果支持A/T/N模型在临床实践中的适用性。

核心结论

  • 内侧和外侧颞叶是A+受试者tau显著累积的部位,可能作为早期临床变化的标志物。
  • 这是首个在记忆门诊人群中使用18F-flortaucipir PET应用A/T/N模型的研究。
  • 多数患者呈现与阿尔茨海默病连续谱一致的profile,少数呈现提示可能其他神经退行性疾病的profile。
  • 作者认为这些结果支持A/T/N模型在临床实践中的适用性。

研究设计与样本

  • 研究纳入81例来自记忆门诊的主观和客观认知障碍患者。
  • 通过淀粉样蛋白PET和结构MRI将患者分为A+/A-和N+/N-。
  • 在体素水平比较不同A/N亚组间的tau沉积。
  • 基于A/N亚组确定全局cut point定义T状态,并按A/T/N模型分类。

主要发现

  • A+N+和A+N-亚组tau负荷高于A-N-组。
  • A+N-亚组的显著tau沉积限于内侧和外侧颞叶区域。
  • 全局cut point可将A+N+和A+N-与A-N-受试者区分。
  • A/T/N分类中23%患者生物标志物profile阴性,58%属阿尔茨海默病连续谱,19%为非AD病理改变。

关键数值与推荐

  • T状态通过基于A/N亚组的全局cut point定义,原文未报告具体阈值。
  • A/T/N分类比例:阴性profile 23%,阿尔茨海默病连续谱58%,非AD病理改变19%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The A/T/N model is a research framework proposed to investigate Alzheimer's disease (AD) pathological bases (i.e., amyloidosis A, neurofibrillary tangles T, and neurodegeneration N). The application of this system on clinical populations is still limited. The aim of the study is to evaluate the topography of T distribution by 18F-flortaucipir PET in relation to A and N and to describe the A/T/N status through imaging biomarkers in memory clinic patients. METHODS: Eighty-one patients with subjective and objective cognitive impairment were classified as A+/A- and N+/N- through amyloid PET and structural MRI. Tau deposition was compared across A/N subgroups at voxel level. T status was defined through a global cut point based on A/N subgroups and subjects were categorized following the A/T/N model. RESULTS: A+N+ and A+N- subgroups showed higher tau burden compared to A-N- group, with A+N- showing significant deposition limited to the medial and lateral temporal regions. Global cut point discriminated A+N+ and A+N- from A-N- subjects. On A/T/N classification, 23% of patients showed a negative biomarker profile, 58% fell within the Alzheimer's continuum, and 19% of the sample was characterized by non-AD pathologic change. CONCLUSION: Medial and lateral temporal regions represent a site of significant tau accumulation in A+ subjects and possibly a useful marker of early clinical changes. This is the first study in which the A/T/N model is applied using 18F-flortaucipir PET in a memory clinic population. The majority of patients showed a profile consistent with the Alzheimer's continuum, while a minor percentage showed a profile suggestive of possible other neurodegenerative diseases. These results support the applicability of the A/T/N model in clinical practice.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Dodich A, Mendes A, Assal F, et al. The A/T/N model applied through imaging biomarkers in a memory clinic. Eur J Nucl Med Mol Imaging. 2019. PMID: 31792573. doi:10.1007/s00259-019-04536-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。